BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Exopharm Ltd.

Headquarters: Melbourne, Australia
Year Founded: 2013
Status: Public
Industry Sector: CommercialServices
CEO: Jason Alan Carroll, MBA
Number Of Employees: N/A
Enterprise Value: $3,515,337
PE Ratio: -2.88
Exchange/Ticker 1: ASX:EX1
Exchange/Ticker 2: N/A
Latest Market Cap: $30,123,153

BioCentury | Apr 7, 2023
Management Tracks

CFO Rajavelu resigns at Fulcrum

Plus: New CBO at Biorchestra, and updates from Cystic Fibrosis Foundation and Qnovia
BioCentury | May 2, 2022
Emerging Company Profile

Mermaid: taking antibodies below the cell surface

Australian-German newco is delivering antibody therapies inside liver cells by encoding them as mRNA
BioCentury | Nov 18, 2021
Deals

China Summit Highlights: Real-world evidence, medtech and deals

Biotech leaders from three continents, Debra Yu, Henk Joos and David Oxley, discuss RWE, medtech, precision medicine and China’s role in global deals
BioCentury | Oct 6, 2021
Management Tracks

Weinstein becomes CFO at Caris Life Sciences

Plus: Kezar, PDS, aTyr, Rosewell, Orum and more
Items per page:
1 - 4 of 4